(Q38362817)

2 September 2017

1 reference

title

Clozapine: new research on efficacy and mechanism of action (English)

1 reference

2 September 2017

H Y Meltzer

1

1 reference

2 September 2017

B Bastani

series ordinal

2

1 reference

2 September 2017

L Ramirez

series ordinal

3

1 reference

2 September 2017

S Matsubara

series ordinal

4

1 reference

2 September 2017

1 January 1989

1 reference

European archives of psychiatry and neurological sciences

2 September 2017

1 reference

2 September 2017

238

1 reference

2 September 2017

332-339

1 reference

2 September 2017

5-6

1 reference

Serotonin-dopamine interactions in the nigrostriatal system

2 September 2017

1 reference

12 December 2020

Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors

1 reference

12 December 2020

Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors

1 reference

12 December 2020

Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex

1 reference

12 December 2020

RMI-81,582, a novel antipsychotic drug

1 reference

12 December 2020

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

12 December 2020

Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women

1 reference

12 December 2020

Dopamine receptor subtype imbalance in schizophrenia

1 reference

12 December 2020

Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist

1 reference

12 December 2020

Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics

1 reference

12 December 2020

Treatment of schizophrenia

1 reference

12 December 2020

Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine

1 reference

12 December 2020

Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

1 reference

12 December 2020

New insights into schizophrenia through atypical antipsychotic drugs

1 reference

12 December 2020

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

1 reference

12 December 2020

The dopamine hypothesis of schizophrenia: a review

1 reference

12 December 2020

Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients

1 reference

12 December 2020

D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.

1 reference

12 December 2020

Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat

1 reference

12 December 2020

An example of European multicenter trials: multispectral analysis of clozapine

1 reference

12 December 2020

Dopamine as a mediator of a central stabilizing system

1 reference

12 December 2020

Catecholamine utilization in specific rat brain nuclei after short-term hyperprolactinaemia.

1 reference

12 December 2020

Influence of antipsychotics and serotonin antagonists on presynaptic receptors modulating the release of serotonin in synaptosomes of the nucleus accumbens of rats

1 reference

12 December 2020

D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons

1 reference

12 December 2020

Antagonism of fenfluramine-induced hyperthermia: A measure of central serotonin inhibition

1 reference

12 December 2020

Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Coupling of Dopamine D 1 Recognition Sites with Adenylate Cyclase in Nuclei Accumbens and Caudatus of Schizophrenics

1 reference

12 December 2020

Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei

1 reference

12 December 2020

Effect of clozapine in severe tardive dyskinesia: a case report

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Clozapine-induced agranulocytosis: a situation report up to August 1976.

1 reference

12 December 2020

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years

1 reference

12 December 2020

Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat

1 reference

12 December 2020

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.

1 reference

12 December 2020

Clozapine in tardive dyskinesia

1 reference

12 December 2020

Integrating incidence and prevalence of tardive dyskinesia

1 reference

12 December 2020

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

12 December 2020

Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.

1 reference

12 December 2020

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

1 reference

12 December 2020

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

12 December 2020

Effect of clozapine on human serum prolactin levels

1 reference

12 December 2020

Clozapine: neuroendocrine studies of an atypical neuroleptic.

1 reference

12 December 2020

Dopamine autoreceptor stimulation: Clinical significance

1 reference

12 December 2020

Clinical importance of D-1 and D-2 receptors

1 reference

12 December 2020

Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat

1 reference

12 December 2020

Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation

1 reference

12 December 2020

Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.

1 reference

12 December 2020

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

12 December 2020

Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Fluperlapine in 104 schizophrenic patients. Open multicenter trial

1 reference

12 December 2020

Serotonin in the basal ganglia: functions and interactions with other neuronal pathways.

1 reference

12 December 2020

Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo

1 reference

12 December 2020

The risks and benefits of clozapine versus chlorpromazine

1 reference

12 December 2020

In vivo dopaminergic activity from nucleus accumbens, substantia nigra and ventral tegmental area in the freely moving rat: basal neurochemical output and prolactin effect

1 reference

12 December 2020

Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists

1 reference

12 December 2020

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

1 reference

12 December 2020

Clozapine--a serotonin antagonist?

1 reference

12 December 2020

Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs

1 reference

12 December 2020

Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo.

1 reference

12 December 2020

Molecular pathology of schizophrenia: more than one disease process?

1 reference

12 December 2020

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

1 reference

12 December 2020

Positive and negative schizophrenic symptoms and the role of dopamine

1 reference

12 December 2020

Effect of clozapine on the metabolism of serotonin in rat brain

1 reference

12 December 2020

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

12 December 2020

The effect of fluperlapine in acute psychotic patients

1 reference

12 December 2020

Serotonergic involvement with neuroleptic catalepsy

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00449814

1 reference

2 September 2017

1 reference